Validation of endothelin-1 as a predictor of adverse prognosis in coronary artery disease patients with impaired kidney function with or without diabetes
31 August 2025 (16:15 - 17:00)
Organised by: 

About the speaker

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
6 More presentations in this session

Doctor C. HUANG (Taipei, TW)

Doctor E. Steinacher (Vienna, AT)
Access the full session
The Event
ESC Congress 2025
31 August 2025
16:15 CET
You may be interested in
Congress Session
Congress Session



